Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_assertion description "[On multivariate analysis, TA2 adenomas were more likely to have a KRAS mutation [odds ratio (OR) 6.6, 95% confidence interval (CI), 3.0-14.2], MGMT loss (OR 6.2, 95% CI, 2.4-16.0), or p53 overexpression (OR 5.6, 95% CI, 2.3-13.7) than TA1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_assertion evidence source_evidence_literature NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_assertion SIO_000772 21263241 NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_assertion wasDerivedFrom befree-20140225 NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_assertion wasGeneratedBy ECO_0000203 NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP453939.RAiZbfkjLPjVLM_COUqbkbPeJI-1psKg-gK5u0q3r--Uw130_provenance.